Section 1.1 Name
The name of this Organization is EAST ASIAN GYNECOLOGIC ONCOLOGY TRIAL GROUP, hereinafter referred to as "EAGOT".
JGOG · KGOG · CHISGO · TGOG — four national trial groups, one East Asian network
Approved by the president of CHISGO, KGOG, TGOG and CHISGO at the foundation meeting on 2021/11/19 and will be discussed whether modification is necessary at the next general meeting.
The name of this Organization is EAST ASIAN GYNECOLOGIC ONCOLOGY TRIAL GROUP, hereinafter referred to as "EAGOT".
Office of EAGOT shall be determined by the Council of EAGOT. Normally this will be collocated with the area of residence of the Chair. EAGOT may also have offices at other places as determined by Council.
English shall be the official language of EAGOT and shall be used for EAGOT purposes.
EAGOT consist of national clinical trial groups that coordinates and promotes clinical trials within East-Asia for women with gynecological cancer. This coordination is particularly relevant for academic clinical trials, translational research, research on rare diseases, and for clinical trials sponsored by industry and governments to perform multinational studies in East Asia.
The purpose of EAGOT is to conduct international clinical trials in an effort to provide best treatments to Asian women affected by gynecological cancer.
Annual dues for all categories of membership shall be recommended by Council. Payment of annual dues entitles the Regular Member to vote, and receive an opportunity of participation in clinical trial and other benefits of membership.
Annual due for each member group is to be paid at the beginning of each calendar year in accordance with established Policy and Procedures of EAGOT. Annual membership fee is 3000USD.
Regular members who have abided by their duties shall have the rights to propose, decide at the Board of Council and Committees, and elect and be elected to Council Members as defined by the bylaws. The other members shall have the right to make proposal at the Board of Council and Committees, but not for decide, elect, and be elected to Council members.
The Annual meeting site shall be determined by Chair and Board of Executive one year prior to the meeting and the date shall be set by the Council in consultation with Board of Executive.
Articles 7-9 will be fixed after 3D/TR committees start discussion.
The standing committees of EAGOT consist of Disease Site Committee including Cervical Cancer, Uterine Corpus Cancer, Ovarian Cancer Committees, and Translational Research Committee. The Chair of EAGOT with the approval of Council may convene ad hoc or special committees. (e.g. Bylaws, Education, Harmonization, Finance, Informatics etc.)
Expenses of EAGOT shall be appropriated by membership fee, contribution and other dues. (And admission fee, when a new member joins)
The fiscal year of EAGOT lasts for 1 year from beginning of new year (or the general assembly.)
Any proposal for amendment to the bylaws must be submitted to the Board of Council at least 2 (or 3) months before it meets. In no case shall the bylaws be amended unless the amendment was adopted by two-third of the Board of Council.
Dissolution shall be proposed, processed and voted upon in the same manner as stipulated in these Bylaws for Amendments.
Last updated at 19th November 2021.